• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL1401904 右旋兰索拉唑 dexlansoprazole Active ingredient Chemical Drugs(3.1) New Drug Application 2015-02-13 中美华世通生物医药科技(武汉)有限公司 Waterstone Pharmaceuticals (WUHAN) Co Ltd Certificate Issued 2016-05-19 view
CXHL1401449 艾曲泊帕片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-10-30 中美华世通生物医药科技(武汉)有限公司 Waterstone Pharmaceuticals (WUHAN) Co Ltd Certificate Issued 2016-03-28 view
CXHL1401447 艾曲泊帕 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2014-10-30 中美华世通生物医药科技(武汉)有限公司 Waterstone Pharmaceuticals (WUHAN) Co Ltd Certificate Issued 2016-03-28 view
CXHL1401450 艾曲泊帕片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-10-30 中美华世通生物医药科技(武汉)有限公司 Waterstone Pharmaceuticals (WUHAN) Co Ltd Certificate Issued 2016-03-28 view
CXHL1401448 艾曲泊帕片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-10-30 中美华世通生物医药科技(武汉)有限公司 Waterstone Pharmaceuticals (WUHAN) Co Ltd Certificate Issued 2016-03-28 view